Using a novel cellular platform to optimize CRISPR/CAS9 technology for the gene therapy of AIDS.
10.1007/s13238-017-0453-z
- Author:
Jingjin HE
1
;
Thanutra ZHANG
2
;
Xuemei FU
3
Author Information
1. The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, 518033, China.
2. Division of Biological Sciences, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA.
3. The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, 518033, China. fxmzj2004@163.com.
- Publication Type:Letter
- MeSH:
Acquired Immunodeficiency Syndrome;
genetics;
therapy;
CRISPR-Cas Systems;
Genetic Therapy;
methods;
Humans
- From:
Protein & Cell
2017;8(11):848-852
- CountryChina
- Language:English
